1. Home
  2. HCWB vs LNKS Comparison

HCWB vs LNKS Comparison

Compare HCWB & LNKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCWB
  • LNKS
  • Stock Information
  • Founded
  • HCWB 2018
  • LNKS 1995
  • Country
  • HCWB United States
  • LNKS Malaysia
  • Employees
  • HCWB N/A
  • LNKS N/A
  • Industry
  • HCWB Biotechnology: Pharmaceutical Preparations
  • LNKS
  • Sector
  • HCWB Health Care
  • LNKS
  • Exchange
  • HCWB Nasdaq
  • LNKS NYSE
  • Market Cap
  • HCWB 10.8M
  • LNKS 8.7M
  • IPO Year
  • HCWB 2021
  • LNKS 2024
  • Fundamental
  • Price
  • HCWB $4.30
  • LNKS $0.64
  • Analyst Decision
  • HCWB Strong Buy
  • LNKS
  • Analyst Count
  • HCWB 1
  • LNKS 0
  • Target Price
  • HCWB $35.00
  • LNKS N/A
  • AVG Volume (30 Days)
  • HCWB 116.1K
  • LNKS 81.4K
  • Earning Date
  • HCWB 08-13-2025
  • LNKS 08-11-2025
  • Dividend Yield
  • HCWB N/A
  • LNKS N/A
  • EPS Growth
  • HCWB N/A
  • LNKS N/A
  • EPS
  • HCWB N/A
  • LNKS N/A
  • Revenue
  • HCWB $1,445,145.00
  • LNKS $5,088,489.00
  • Revenue This Year
  • HCWB $178.36
  • LNKS N/A
  • Revenue Next Year
  • HCWB N/A
  • LNKS N/A
  • P/E Ratio
  • HCWB N/A
  • LNKS N/A
  • Revenue Growth
  • HCWB N/A
  • LNKS N/A
  • 52 Week Low
  • HCWB $3.55
  • LNKS $0.45
  • 52 Week High
  • HCWB $100.80
  • LNKS $10.27
  • Technical
  • Relative Strength Index (RSI)
  • HCWB 42.79
  • LNKS N/A
  • Support Level
  • HCWB $4.02
  • LNKS N/A
  • Resistance Level
  • HCWB $4.44
  • LNKS N/A
  • Average True Range (ATR)
  • HCWB 0.31
  • LNKS 0.00
  • MACD
  • HCWB 0.08
  • LNKS 0.00
  • Stochastic Oscillator
  • HCWB 31.85
  • LNKS 0.00

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

About LNKS LINKERS INDUSTRIES LIMITED

Linkers Industries Ltd is a company which acts as a manufacturer and a supplier of wire, cable harnesses with their manufacturing operations in Malaysia. Wire/cable harness refers to an assembly of wires/cables bound together with straps, cable ties and electrical tapes to transmit signals or electrical power. Company works closely with customers in each stage of a product's life cycle, including design, prototyping and production. Geographically company provides services in Thailand, Malaysia, Switzerland, United States of America, and many others, maximum revenue gained from Thailand.

Share on Social Networks: